Dabigatran - advancing stroke medicine

Professor John Eikelboom (McMaster University, Canada), Professor Gregory Lip (University of Birmingham Centre for Cardiovascular Sciences, UK), Professor Christoph Diener (University of Essen, Germany) and Professor John Camm (St. George’s Hospital, UK) come together to discuss how new treatments such as Pradaxa^® are advancing stroke medicine. The video highlights key efficacy and safety results for Pradaxa^® from the RE-LY^® trial and what they will mean for patients with atrial fibrillation (AF).